The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases.
Chaoyi LiJie RenMengfei ZhangHuakun WangFang YiJunjiao WuYu TangPublished in: Cellular and molecular life sciences : CMLS (2022)
Microglia are resident immune cells in the brain and play a central role in the development and surveillance of the nervous system. Extensive gliosis is a common pathological feature of several neurodegenerative diseases, such as Alzheimer's disease (AD), the most common cause of dementia. Microglia can respond to multiple inflammatory insults and later transform into different phenotypes, such as pro- and anti-inflammatory phenotypes, thereby exerting different functions. In recent years, an increasing number of studies based on both traditional bulk sequencing and novel single-cell/nuclear sequencing and multi-omics analysis, have shown that microglial phenotypes are highly heterogeneous and dynamic, depending on the severity and stage of the disease as well as the particular inflammatory milieu. Thus, redirecting microglial activation to beneficial and neuroprotective phenotypes promises to halt the progression of neurodegenerative diseases. To this end, an increasing number of studies have focused on unraveling heterogeneous microglial phenotypes and their underlying molecular mechanisms, including those due to epigenetic and non-coding RNA modulations. In this review, we summarize the epigenetic mechanisms in the form of DNA and histone modifications, as well as the general non-coding RNA regulations that modulate microglial activation during immunopathogenesis of neurodegenerative diseases and discuss promising research approaches in the microglial era.
Keyphrases
- inflammatory response
- single cell
- neuropathic pain
- lipopolysaccharide induced
- lps induced
- dna methylation
- rna seq
- anti inflammatory
- gene expression
- spinal cord
- spinal cord injury
- oxidative stress
- high throughput
- nucleic acid
- public health
- machine learning
- cerebral ischemia
- mild cognitive impairment
- white matter
- multiple sclerosis
- single molecule
- patient safety
- resting state
- blood brain barrier
- cognitive impairment
- quality improvement
- brain injury
- neural network